Navigation Links
Ionian Technologies, Inc. Signs Molecular Diagnostic Manufacturing Agreement With Roche Diagnostics

SAN DIEGO, Nov. 12 /PRNewswire/ -- Ionian Technologies, Inc. and Roche Diagnostics Corporation have entered into a collaborative agreement based on Ionian's rapid isothermal nucleic acid amplification technology. Under this agreement, Roche will identify new applications and customers for the technology and will bring these opportunities to Ionian. Roche will have exclusive manufacturing rights for these specific opportunities upon commercialization.

"We are excited by this collaboration as it allows Ionian to continue to focus on its core strengths, including technology and assay development, while leveraging the business development, sales, and manufacturing expertise of Roche, a worldwide leader in healthcare and diagnostics," said Andrew P. Miller, Chief Executive Officer of Ionian Technologies, Inc.

Ionian's isothermal amplification technology, the NEAR Assay(TM) provides for detection of both DNA and RNA from bacterial or viral pathogens in less than 10 minutes. Furthermore, the technology is amenable to raw or unpurified samples, obviating the need for complex sample processing and purification steps. Based on these key attributes, Ionian's technology is ideally suited for point-of-care and point-of-use settings.

Founded in 2000, Ionian Technologies, Inc. is focused on commercializing its proprietary technology for the rapid detection of nucleic acids in various fields, including human in vitro diagnostics, food safety, biodefense, agriculture, and veterinary applications. Ionian is privately held and is based in San Diego, CA.

    For more information, contact -
    Ionian Technologies, Inc.
    Andrew P. Miller, Ph.D.
    Chief Executive Officer
    858-642-0998, ext. 220

SOURCE Ionian Technologies, Inc.

SOURCE Ionian Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
3. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
4. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
5. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
6. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
7. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
8. Wound Management Technologies, Inc. Announces Evidence Based Study
9. OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer
10. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
11. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
Post Your Comments:
(Date:11/27/2015)... 2015 --> ... online. The potential to save costs, improve treatment quality ... from fully exploited as yet. Here, particular emphasis is ... via mobile tablet or directly at the patients, bedside. ... ) -->      (Photo: ...
(Date:11/27/2015)... Research and Markets ( ) has announced the ... report to their offering. ... author the present scenario and growth prospects of the ... market size, the report considers revenue generated from the ... copper IUDs. The report forecasts the global intrauterine devices ...
(Date:11/26/2015)... November 26, 2015 Un nuevo ... Bremachlorin para el cáncer avanzado.   --> ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... la inmunoterapia con la terapia fotodinámica de Bremachlorin para ... Research . --> Clinical Cancer Research . ...
Breaking Medicine Technology:
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug Delivery ... to integrate dose form selection in early phase drug development. The first of ... and bringing together the UK’s emerging life sciences companies, corporate partners, and investors, ...
(Date:11/26/2015)... ... November 26, 2015 , ... PRMA Plastic Surgery is updating ... our surgeons performed their 6,000th free flap breast reconstruction surgery! , “What an accomplishment ... day excited to rebuild lives and it’s an honor to have served all of ...
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/26/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk based contact center ... reliability. , The new Q-Suite 6 platform is based on the latest Java Enterprise ... a specific piece of software for many key components of the suite. Much of ...
Breaking Medicine News(10 mins):